ALNAQ — Allena Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Allena Pharmaceuticals Announces $5 mln Bought Deal Offering
Brief: Empery Asset Management Lp Reports 8.71% Passive Stake In Allena Pharmaceuticals As Of June 3
Brief: Allena Pharmaceuticals Announces $15.0 Mln Registered Direct Offering
Brief: Allena Pharmaceuticals Reports Q1 Loss Per Share Of $0.31
Brief: Allena Pharmaceuticals Reports Q4 Loss Per Share Of $0.47
Nasdaq Trade Halt Market Wide Circuit Breaker Halt: LEVEL 1 AT 08:37 AM
Brief: Allena Pharma Announces Streamlined Design For Urirox-2, Second Pivotal Clinical Trial Of Reloxaliase For Enteric Hyperoxaluria
U.S. STOCKS ON THE MOVE-Akers Biosciences, Powell Industries, Duluth, Omeros, KLX Energy
Allena Pharma: Falls after announcing cost-cutting measures
Brief: Allena Pharmaceuticals Provides Updates On Reloxaliase Development Program And Corporate Activities
Brief: Allena Pharmaceuticals Estimates It Will Incur Charges Of About $0.5 Million To $0.6 Million For One-Time Severance & Employee Related Costs In Q4 Of 2019
Brief: Allena Pharmaceuticals Reports Third Quarter 2019 Financial Results And Provides Business Update
Allena's hyperoxaluria study data falls short of expectations - Credit Suisse
Brief: Allena Pharmaceuticals Reports Positive Reloxaliase Topline Results From Urirox-1 Trial And From Study 206
U.S. STOCKS ON THE MOVE-Qualcomm, Expedia, Party City, Ralph Lauren
U.S. STOCKS ON THE MOVE-Qualcomm, Expedia Group, Party City , Ralph Lauren, ObsEva
NASDAQ RESUMED
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE
NASDAQ RESUMED